Follow
Nicola Normanno
Nicola Normanno
Istituto Nazionale dei Tumori-Fondazione G. Pascale, Napoli
Verified email at istitutotumori.na.it
Title
Cited by
Cited by
Year
Epidermal growth factor-related peptides and their receptors in human malignancies
DS Salomon, R Brandt, F Ciardiello, N Normanno
Critical reviews in oncology/hematology 19 (3), 183-232, 1995
37291995
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E Van Cutsem, A Cervantes, R Adam, A Sobrero, JH Van Krieken, ...
Annals of Oncology 27 (8), 1386-1422, 2016
33912016
Epidermal growth factor receptor (EGFR) signaling in cancer
N Normanno, A De Luca, C Bianco, L Strizzi, M Mancino, MR Maiello, ...
Gene 366 (1), 2-16, 2006
24412006
Endocrine therapy plus zoledronic acid in premenopausal breast cancer
M Gnant, B Mlineritsch, W Schippinger, G Luschin-Ebengreuth, ...
New England Journal of Medicine 360 (7), 679-691, 2009
12762009
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
F Mosele, J Remon, J Mateo, CB Westphalen, F Barlesi, MP Lolkema, ...
Annals of Oncology 31 (11), 1491-1505, 2020
8432020
The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches
A De Luca, MR Maiello, A D'Alessio, M Pergameno, N Normanno
Expert opinion on therapeutic targets 16 (sup2), S17-S27, 2012
8052012
KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer
W De Roock, V De Vriendt, N Normanno, F Ciardiello, S Tejpar
The lancet oncology 12 (6), 594-603, 2011
6912011
Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
N Normanno, S Tejpar, F Morgillo, A De Luca, E Van Cutsem, F Ciardiello
Nature reviews Clinical oncology 6 (9), 519-527, 2009
5072009
Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment.
N Normanno, C Bianco, A De Luca, MR Maiello, DS Salomon
Endocrine-related cancer 10 (1), 1-21, 2003
4742003
The role of the EGFR signaling in tumor microenvironment
A De Luca, A Carotenuto, A Rachiglio, M Gallo, MR Maiello, D Aldinucci, ...
Journal of cellular physiology 214 (3), 559-567, 2008
4562008
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
A Cervantes, R Adam, S Roselló, D Arnold, N Normanno, J Taïeb, ...
Annals of Oncology 34 (1), 10-32, 2023
4002023
Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer
N Normanno, M Di Maio, E De Maio, A De Luca, A de Matteis, A Giordano, ...
Endocrine-related cancer 12 (4), 721-747, 2005
3792005
The ErbB receptors and their ligands in cancer: an overview
N Normanno, C Bianco, L Strizzi, M Mancino, MR Maiello, AD Luca, ...
Current drug targets 6 (3), 243-257, 2005
3742005
Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth
N Normanno, M Campiglio, A De Luca, G Somenzi, M Maiello, ...
Annals of Oncology 13 (1), 65-72, 2002
3492002
Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions
A Morabito, E De Maio, M Di Maio, N Normanno, F Perrone
The oncologist 11 (7), 753-764, 2006
3302006
Implementing TMB measurement in clinical practice: considerations on assay requirements
R Büttner, JW Longshore, F López-Ríos, S Merkelbach-Bruse, ...
ESMO open 4 (1), e000442, 2019
3062019
Leptin signaling in breast cancer: an overview
D Cirillo, AM Rachiglio, R La Montagna, A Giordano, N Normanno
Journal of cellular biochemistry 105 (4), 956-964, 2008
2892008
The role of EGF-related peptides in tumor growth
N Normanno, C Bianco, A De Luca, DS Salomon
Front Biosci 6 (1), D685-707, 2001
2852001
Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and …
A Morabito, MC Piccirillo, F Falasconi, G De Feo, A Del Giudice, J Bryce, ...
The oncologist 14 (4), 378-390, 2009
2342009
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
J Pascual, G Attard, FC Bidard, G Curigliano, L de Mattos-Arruda, ...
Annals of Oncology 33 (8), 750-768, 2022
2302022
The system can't perform the operation now. Try again later.
Articles 1–20